OSTX
7:40 AM
News Updates
Tue, May 26, 2026
1 updatesMon, May 18, 2026
1 updatesOSTX
6:30 AM
OS Therapies Reports First Quarter 2026 Financials and Provides Business Update
Presentation / Abstract • Phase 2ASCO 2026 data release Fri, Jun 5, 2026ostherapies.com
Fri, May 15, 2026
1 updatesOSTX
4:05 PM
Thu, May 14, 2026
1 updatesOSTX
7:30 AM
Thu, Apr 30, 2026
1 updatesOSTX
6:00 AM
OS Therapies Announces EMA Initiates Rolling Review of Conditional Marketing Authorization Application for OST-HER2 in the Prevention or Delay of Recurrence in Fully Resected Pulmonary Metastatic Osteosarcoma
Results Call • Phase 2Call Thu, Apr 30, 2026, 8:30 AM ETostherapies.com
Mon, Apr 27, 2026
1 updatesOSTX
4:01 PM
OS Therapies Schedules OST-HER2 Pharmacodynamic Response Biomarker Conference Call on April 30, 2026 at 8:30am ET
Results CallCall Thu, Apr 30, 2026, 8:30 AM ETostherapies.com
Thu, Apr 16, 2026
1 updatesMon, Apr 13, 2026
1 updatesWed, Apr 8, 2026
1 updatesOSTX
11:38 AM
OS Therapies Appoints Craig Eagle, MD as Strategic Advisor
ostherapies.com